Skip to main content
SpringerLink
Log in

Advances in Early Detection and Diagnostic Adjuncts in Oral Cavity Cancer

  • Chapter
  • First Online:
Contemporary Oral Oncology

Abstract

Oral and pharyngeal cancers combined rank within the top ten most common malignancies in the world for men, with an estimated global incidence of oral cancer alone at approximately 275,000 [1]. Over 90 % of oral cancers affecting the lips, gingiva, tongue, buccal mucosa, floor of mouth and hard palate arise from the squamous epithelium and are thus termed oral squamous cell carcinomas (OSCCs) [2, 3]. Conversely, neoplasms originating from the epithelial lining of oropharynx are called oropharyngeal squamous cell carcinomas (OPSCCs) [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

Change history

  • 07 April 2021

    This book was inadvertently published with the incorrect city and country on the affiliation of Dr. Noah Kondamudi. This has now been corrected in the book.

References

  1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16. [Review].

    Article  PubMed  Google Scholar 

  2. McCullough MJ, Prasad G, Farah CS. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Aust Dent J. 2010;55 Suppl 1:61–5.

    Article  PubMed  Google Scholar 

  3. Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141(5):509–20. [Review].

    Article  PubMed  Google Scholar 

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  5. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52(4):195–215.

    Article  PubMed  Google Scholar 

  6. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143–54.

    Article  CAS  PubMed  Google Scholar 

  7. van Monsjou HS, Lopez-Yurda MI, Hauptmann M, van den Brekel MW, Balm AJ, Wreesmann VB. Oral and oropharyngeal squamous cell carcinoma in young patients: the Netherlands Cancer Institute experience. Head Neck. 2013;35(1):94–102.

    Article  PubMed  Google Scholar 

  8. Allen K, Farah CS. Patient perspectives of diagnostic delay for suspicious oral mucosal lesions. Aust Dent J. 2015;60(3):397–403. doi: 10.1111/adj.12246.

  9. Farah CS, Simanovic B, Dost F. Oral cancer in Australia 1982–2008: a growing need for opportunistic screening and prevention. Aust Dent J. 2014;59(3):349–59.

    Article  CAS  PubMed  Google Scholar 

  10. Irjala H, Matar N, Remacle M, Georges L. Pharyngo-laryngeal examination with the narrow band imaging technology: early experience. Eur Arch Otorhinolaryngol. 2011;268(6):801–6.

    Google Scholar 

  11. Katada C, Nakayama M, Tanabe S, Koizumi W, Masaki T, Takeda M, et al. Narrow band imaging for detecting metachronous superficial oropharyngeal and hypopharyngeal squamous cell carcinomas after chemoradiotherapy for head and neck cancers. Laryngoscope. 2008;118(10):1787–90.

    Google Scholar 

  12. Hayashi T, Muto M, Hayashi R, Minashi K, Yano T, Kishimoto S, et al. Usefulness of narrow-band imaging for detecting the primary tumor site in patients with primary unknown cervical lymph node metastasis. Jpn J Clin Oncol. 2010;40(6):537–41.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Piazza C, Dessouky O, Peretti G, Cocco D, De Benedetto L, Nicolai P. Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature. Acta Otorhinolaryngol Ital. 2008;28(2):49–54.

    Google Scholar 

  14. Watanabe A, Taniguchi M, Tsujie H, Hosokawa M, Fujita M, Sasaki S. The value of narrow band imaging endoscope for early head and neck cancers. Curr Opin Otolaryngol Head Neck Surg. 2008;138(4):446–51. [Comparative Study Research Support, Non-U.S. Gov't].

    Google Scholar 

  15. Muto M, Nakane M, Katada C, Sano Y, Ohtsu A, Esumi H, et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer. 2004;101(6):1375–81.

    Google Scholar 

  16. Fujii S, Yamazaki M, Muto M, Ochiai A. Microvascular irregularities are associated with composition of squamous epithelial lesions and correlate with subepithelial invasion of superficial-type pharyngeal squamous cell carcinoma. Histopathology. 2010;56(4):510–22.

    Article  PubMed  Google Scholar 

  17. Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E, et al. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid. Head Neck Oncol. 2012;4(1):15.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wang B, Zhang S, Yue K, Wang X-D. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer. 2013;32(11):614.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Muto M, Katada C, Sano Y, Yoshida S. Narrow band imaging: a new diagnostic approach to visualize angiogenesis in superficial neoplasia. Clin Gastroenterol Hepatol. 2005;3(7 Suppl 1):S16–20.

    Article  PubMed  Google Scholar 

  20. Gómez I, Seoane J, Varela-Centelles P, Diz P, Takkouche B. Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis. Eur J Oral Sci. 2009;117(5):541–6.

    Article  PubMed  Google Scholar 

  21. Pitchers M, Martin C. Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival. Br J Cancer. 2006;94(7):955–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 2003;61(7):751–8.

    Article  PubMed  Google Scholar 

  23. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001;2(4):239–51.

    Article  CAS  PubMed  Google Scholar 

  24. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Lo Muzio L. Costs and effectiveness in the care of patients with oral and pharyngeal cancer: analysis of a paradox. Eur J Cancer Prev. 2002;11(3):205–8.

    Article  CAS  PubMed  Google Scholar 

  25. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.

    Article  CAS  PubMed  Google Scholar 

  26. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010;46(6):423–5.

    Article  PubMed  Google Scholar 

  27. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4–5):301–8.

    Article  CAS  PubMed  Google Scholar 

  28. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37(1):1–10. [Review].

    Article  PubMed  Google Scholar 

  29. Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med. 2003;14(4):253–67.

    Article  CAS  PubMed  Google Scholar 

  30. McCullough M, Jaber M, Barrett AW, Bain L, Speight PM, Porter SR. Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol. 2002;38(4):391–3.

    Article  CAS  PubMed  Google Scholar 

  31. Farah CS, McCullough MJ. Oral cancer awareness for the general practitioner: new approaches to patient care. Aust Dent J. 2008;53(1):2–10.

    Article  CAS  PubMed  Google Scholar 

  32. Van Der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23. [Review].

    Article  PubMed  Google Scholar 

  33. Dost F, Le Cao KA, Ford PJ, Farah CS. A retrospective analysis of clinical features of oral malignant and potentially malignant disorders with and without oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2013;116(6):725–33.

    Article  Google Scholar 

  34. Farah CS, Woo SB, Zain RB, Sklavounou A, McCullough MJ, Lingen M. Oral cancer and oral potentially malignant disorders. Int J Dent. 2014;2014:853479.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Natarajan E, Eisenberg E. Contemporary concepts in the diagnosis of oral cancer and precancer. Dent Clin N Am. 2011;55(1):63–88.

    Article  PubMed  Google Scholar 

  36. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol. 2001;37(3):262–7.

    Article  CAS  PubMed  Google Scholar 

  37. Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14(3):229–43. [Review].

    Article  CAS  PubMed  Google Scholar 

  38. Mignogna MD, Fedele S, Lo RL. Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol. 2006;42(8):819–24.

    Article  PubMed  Google Scholar 

  39. Panzarella V, Pizzo G, Calvino F, Compilato D, Colella G, Campisi G. Diagnostic delay in oral squamous cell carcinoma: the role of cognitive and psychological variables. Int J Oral Sci. 2014;6(1):39–45.

    Article  PubMed  Google Scholar 

  40. Epstein JB, Guneri P, Boyacioglu H, Abt E. The limitations of the clinical oral examination in detecting dysplastic oral lesions and oral squamous cell carcinoma. J Am Dent Assoc. 2012;143(12):1332–42.

    Article  PubMed  Google Scholar 

  41. Thomson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg. 2002;31(3):262–6.

    Article  CAS  PubMed  Google Scholar 

  42. Downer MC, Evans AW, Hallett CMH, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol. 1995;23(2):84–8.

    Article  CAS  PubMed  Google Scholar 

  43. Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. Br Dent J. 2003;194(9):497–502. Discussion 493 [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  44. Brocklehurst P, Kujan O, Glenny AM, Oliver R, Sloan P, Ogden G, et al. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2010(11):CD004150. [Review].

    Google Scholar 

  45. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365(9475):1927–33. [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  46. Force USPST. Screening for oral cancer: draft recommendation statement. AHRQ publication no. 13-05186-EF-2. AHRQ publication no. 13-05186-EF-2:[AHRQ publication no. 13-05186-EF-2]. Available from: http://www.uspreventiveservicestaskforce.org/draftrec2.htm.

  47. McIntosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral Oncol. 2009;45(12):e227–31.

    Article  CAS  PubMed  Google Scholar 

  48. Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol. 2007;43(8):820–4.

    Article  CAS  PubMed  Google Scholar 

  49. Geoghegan WD, Ackerman GA. Adsorption of horseradish peroxidase, ovomucoid and anti-immunoglobulin to colloidal gold for the indirect detection of concanavalin A, wheat germ agglutinin and goat anti-human immunoglobulin G on cell surfaces at the electron microscopic level: a new method, theory and application. J Histochem Cytochem. 1977;25(11):1187–200.

    Article  CAS  PubMed  Google Scholar 

  50. Liu B, Bian H-j, Bao J-k. Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett. 2010;287(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  51. Hoeben BA, Bussink J, Troost EG, Oyen WJ, Kaanders JH. Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta oncologica (Stockholm, Sweden). 2013;52(7):1257–71.

    Google Scholar 

  52. Farah C, Bhatia N, John K, Lee B. Minimum intervention dentistry in oral medicine. Aust Dent J. 2013;58 Suppl 1:85–94.

    Article  PubMed  Google Scholar 

  53. Mody R, Joshi SA, Chaney W. Use of lectins as diagnostic and therapeutic tools for cancer. J Pharmacol Toxicol Methods. 1995;33(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  54. Diesner SC, Wang X-Y, Jensen-Jarolim E, Untersmayr E, Gabor F. Use of lectin-functionalized particles for oral immunotherapy. Ther Deliv. 2012;3(2):277–90.

    Article  PubMed  Google Scholar 

  55. Barnes L. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.

    Google Scholar 

  56. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39(8):770–80. [Review].

    Article  PubMed  Google Scholar 

  57. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998;34(4):270–5.

    Article  CAS  PubMed  Google Scholar 

  58. Dost F, Lê Cao K, Ford PJ, Ades C, Farah CS. Malignant transformation of oral epithelial dysplasia: a real world evaluation of histopathological grading. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2014;117(3):343–52.

    Article  CAS  Google Scholar 

  59. Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010;10:685.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Silverman Jr S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53(3):563–8. [Research Support, U.S. Gov’t, P.H.S.].

    Article  PubMed  Google Scholar 

  61. Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J. 2011;56(3):253–6. [Review].

    Article  CAS  PubMed  Google Scholar 

  62. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer. 1975;36(3):1021–8.

    Article  CAS  PubMed  Google Scholar 

  63. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ? Oral Oncol. 2004;40(2):120–30. [Review].

    Article  PubMed  Google Scholar 

  64. Xue JL, Fan MW, Wang SZ, Chen XM, Li Y, Wang L. A clinical study of 674 patients with oral lichen planus in China. J Oral Pathol Med. 2005;34(8):467–72.

    Article  PubMed  Google Scholar 

  65. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46(2):207–14. [Review].

    Article  PubMed  Google Scholar 

  66. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(4):431–6.

    Article  CAS  PubMed  Google Scholar 

  67. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med. 2002;13(5):390–6. [Review].

    Article  PubMed  Google Scholar 

  68. Sousa FA, Rosa LE. Oral lichen planus: clinical and histopathological considerations. Braz J Otorhinolaryngol. 2008;74(2):284–92. [Review].

    Article  PubMed  Google Scholar 

  69. van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007;43(8):742–8. [Review].

    Article  PubMed  CAS  Google Scholar 

  70. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;18.

    Google Scholar 

  71. Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol. 2004;40(1):77–83.

    Article  CAS  PubMed  Google Scholar 

  72. Mignogna MD, Lo Russo L, Fedele S, Ruoppo E, Califano L, Lo Muzio L. Clinical behaviour of malignant transforming oral lichen planus. Eur J Surg Oncol. 2002;28(8):838–43.

    Article  CAS  PubMed  Google Scholar 

  73. Mignogna MD, Fedele S, Lo Russo L, Mignogna C, de Rosa G, Porter SR. Field cancerization in oral lichen planus. Eur J Surg Oncol. 2007;33(3):383–9.

    Article  CAS  PubMed  Google Scholar 

  74. Redahan S, O’Regan E, McCartan B, Toner M. Histological evidence for lichen planus in clinically normal perilesional tissue. Int J Oral Maxillofac Surg. 2005;34(6):674–7.

    Article  CAS  PubMed  Google Scholar 

  75. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E. Metastases in small thickness oral squamous-cell carcinoma arising in oral lichen planus. Med Oncol. 2001;18(2):159–63.

    Article  CAS  PubMed  Google Scholar 

  76. van der Meij EH, Bezemer PD, van der Waal I. Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus. Community Dent Oral Epidemiol. 2002;30(5):342–51. [Review].

    Article  PubMed  Google Scholar 

  77. Lo Muzio L, Mignogna MD, Favia G, Procaccini M, Testa NF, Bucci E. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol. 1998;34(4):239–46.

    Article  CAS  PubMed  Google Scholar 

  78. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 2005;65(17):8017–21.

    Article  CAS  PubMed  Google Scholar 

  79. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol. 1985;60(3):308–15.

    Article  CAS  PubMed  Google Scholar 

  80. Eisenberg E, Krutchkoff DJ. Lichenoid lesions of oral mucosa. Diagnostic criteria and their importance in the alleged relationship to oral cancer. Oral Surg Oral Med Oral Pathol. 1992;73(6):699–704.

    Google Scholar 

  81. Kim J, Yook JI, Lee EH, Ryu MH, Yoon JH, Hong JC, et al. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics. J Oral Pathol Med. 2001;30(2):65–72.

    Article  CAS  PubMed  Google Scholar 

  82. Sousa FA, Paradella TC, Brandao AA, Rosa LE. Oral lichen planus versus epithelial dysplasia: difficulties in diagnosis. Braz J Otorhinolaryngol. 2009;75(5):716–20.

    PubMed  Google Scholar 

  83. De Jong WF, Albrecht M, Banoczy J, van der Waal I. Epithelial dysplasia in oral lichen planus. A preliminary report of a Dutch-Hungarian study of 100 cases. Int J Oral Surg. 1984;13(3):221–5.

    Article  PubMed  Google Scholar 

  84. van der Meij EH, Reibel J, Slootweg PJ, van der Wal JE, de Jong WF, van der Waal I. Interobserver and intraobserver variability in the histologic assessment of oral lichen planus. J Oral Pathol Med. 1999;28(6):274–7.

    Article  PubMed  Google Scholar 

  85. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus. A premalignant lesion? Am J Pathol. 1997;151(2):323–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Accurso BT, Warner BM, Knobloch TJ, Weghorst CM, Shumway BS, Allen CM, et al. Allelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(3):359–66.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Zhang L, Cheng X, Li Y, Poh C, Zeng T, Priddy R, et al. High frequency of allelic loss in dysplastic lichenoid lesions. Lab Invest. 2000;80(2):233–7. [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  88. Mohd Bakri M, Mohd Hussaini H, Rachel Holmes A, David Cannon R, Mary Rich A. Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma. J Oral Microbiol. 2010;2.

    Google Scholar 

  89. Barrett AW, Kingsmill VJ, Speight PM. The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis. 1998;4(1):26–31.

    Article  CAS  PubMed  Google Scholar 

  90. Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34(4):304–8. [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  91. Meurman JH. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010;46(6):411–3.

    Article  PubMed  Google Scholar 

  92. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M. Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer. Alcohol Clin Exp Res. 1999;23(8):1409–15. [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  93. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case–control study of prospectively recorded data. BMJ. 2009;339.

    Google Scholar 

  94. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151(10):727–37.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Moles DR, Downer MC, Speight PM. Meta-analysis of measures of performance reported in oral cancer and precancer screening studies. Br Dent J. 2002;192(6):340–4. [10.1038/sj.bdj.4801370].

    Article  CAS  PubMed  Google Scholar 

  96. Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahé C, et al. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala. India Oral Oncol. 2003;39(6):580–8.

    Article  CAS  PubMed  Google Scholar 

  97. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ. 2005;69(2):255–65.

    Article  PubMed  Google Scholar 

  98. Shuman AG, Entezami P, Chernin AS, Wallace NE, Taylor JMG, Hogikyan ND. Demographics and efficacy of head and neck cancer screening. Otolaryngol Head Neck Surg. 2010;143(3):353–60.

    Article  PubMed  Google Scholar 

  99. Ford PJ, Farah CS. Early detection and diagnosis of oral cancer: strategies for improvement. J Cancer Policy. 2013;1(1–2):e2–7.

    Article  Google Scholar 

  100. Gourin CG, Kaboli KC, Blume EJ, Nance MA, Koch WM. Characteristics of participants in a free oral, head and neck cancer screening program. Laryngoscope. 2009;119(4):679–82.

    Article  PubMed  Google Scholar 

  101. Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M, Macpherson LMD. Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case–control studies. Int J Cancer. 2008;122(12):2811–9.

    Article  CAS  PubMed  Google Scholar 

  102. Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 2006;10(14):1–144. iii-iv.

    Article  CAS  PubMed  Google Scholar 

  103. Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, et al. Cost-effectiveness of oral cancer screening: results from acluster randomized controlled trial in India. Bull World Health Organ. 2009;87(3):200–6.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus–related and –unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612–9.

    Article  PubMed  Google Scholar 

  105. Klassen AC, Juon H-S, Alberg AJ, Reid BC, Meissner HI. Opportunities for oral cancer screening among older African-American women. Prev Med. 2003;37(5):499–506.

    Article  PubMed  Google Scholar 

  106. Cruz GD, Shulman LC, Kumar JV, Salazar CR. The cultural and social context of oral and pharyngeal cancer risk and control among Hispanics in New York. J Health Care Poor Underserved. 2007;18(4):833–46.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Roder D, Currow D. Cancer in aboriginal and torres strait Islander people of Australia. Asian Pac J Cancer Prev. 2009;10(5):729–33.

    PubMed  Google Scholar 

  108. Lalla Y, Matias MA, Farah CS. Oral mucosal disease in an Australian urban Indigenous community using autofluorescence imaging and reflectance spectroscopy. Aust Dent J. 2015;60:216–24.

    Article  CAS  PubMed  Google Scholar 

  109. De Camargo CM, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP. Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck. 2010;32(3):357–67.

    Google Scholar 

  110. Moyer VA. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(1):55–60.

    Article  PubMed  Google Scholar 

  111. Allen K, Farah CS. Screening and referral of oral mucosal pathology: a check-up of Australian dentists. Aust Dent J. 2015;60:52–8.

    Article  CAS  PubMed  Google Scholar 

  112. Association AD. Accreditation standards for dental education programs. Chicago: The Commission; Commission on Dental Accreditation. 2013.

    Google Scholar 

  113. Lingen MW. Assuring dental student head and neck cancer screening competency. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(3):267–8.

    Article  PubMed  Google Scholar 

  114. Choong N, Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin. 2008;58(1):32–53. [Review].

    Article  PubMed  Google Scholar 

  115. Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg. 1988;156(4):273–5.

    Article  CAS  PubMed  Google Scholar 

  116. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol. 2004;40(3):264–73.

    Article  PubMed  Google Scholar 

  117. Ikeda N, Downer MC, Ishii T, Fukano H, Nagao T, Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dent Health. 1995;12(3):133–7.

    CAS  PubMed  Google Scholar 

  118. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health. 1995;12(1):3–7.

    CAS  PubMed  Google Scholar 

  119. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44(1):10–22.

    Article  PubMed  Google Scholar 

  120. Bhatia N, Lalla Y, Vu AN, Farah CS. Advances in Optical Adjunctive Aids for Visualisation and Detection of Oral Malignant and Potentially Malignant Lesions. Int J Dent. 2013;2013:194029.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 1968;65(4):281–393.

    CAS  PubMed  Google Scholar 

  122. Herlin P, Marnay J, Jacob JH, Ollivier JM, Mandard AM. A study of the mechanism of the toluidine blue dye test. Endoscopy. 1983;15(1):4–7.

    Article  CAS  PubMed  Google Scholar 

  123. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. J Am Dent Assoc. 1983;106(3):319–23.

    Article  CAS  PubMed  Google Scholar 

  124. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(4):444–6. [Comparative Study].

    Article  CAS  PubMed  Google Scholar 

  125. Pontén J, Macintyre EH. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand. 1968;74(4):465–86.

    Google Scholar 

  126. Rubin H, YAo A, Chow M. Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density. Proc Natl Acad Sci. 1995;92(17):7734–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Upadhyay J, Rao NN, Upadhyay RB, Agarwal P. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider. Asian Pac J Cancer Prev. 2011;12(7):1757–60. [Evaluation Studies].

    PubMed  Google Scholar 

  128. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc. 2008;139(7):896–905.

    Article  PubMed  Google Scholar 

  129. Allegra E, Lombardo N, Puzzo L, Garozzo A. The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. Acta Otorhinolaryngol Ital. 2009;29(4):187–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  130. Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med. 1996;25(3):97–103.

    Article  CAS  PubMed  Google Scholar 

  131. Silverman Jr S, Migliorati C, Barbosa J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol. 1984;57(4):379–82.

    Article  PubMed  Google Scholar 

  132. Ujaoney S, Motwani MB, Degwekar S, Wadhwan V, Zade P, Chaudhary M, et al. Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: a cross-sectional study. BMC Clin Pathol. 2012;12:6.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(5):535–40.

    Article  CAS  PubMed  Google Scholar 

  134. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83(5):537–47.

    Article  CAS  PubMed  Google Scholar 

  135. Awan K, Yang Y, Morgan P, Warnakulasuriya S. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment. Oral Dis. 2012;18(8):728–33.

    Google Scholar 

  136. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(1):45–50.

    Article  PubMed  Google Scholar 

  137. Cancela-Rodriguez P, Cerero-Lapiedra R, Esparza-Gomez G, Llamas-Martinez S, Warnakulasuriya S. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions. J Oral Pathol Med. 2011;40(4):300–4.

    Article  PubMed  Google Scholar 

  138. Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra WH, Koch WM, Sidransky D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res. 2001;7(7):1963–8. [Research Support, U.S. Gov’t, P.H.S.].

    CAS  PubMed  Google Scholar 

  139. Kerawala CJ, Beale V, Reed M, Martin IC. The role of vital tissue staining in the marginal control of oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2000;29(1):32–5.

    Article  CAS  PubMed  Google Scholar 

  140. Epstein JB, Guneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg. 2009;17(2):79–87. [Review].

    Article  PubMed  Google Scholar 

  141. Su WW, Yen AM, Chiu SY, Chen TH. A community-based RCT for oral cancer screening with toluidine blue. J Dent Res. 2010;89(9):933–7. [Randomized Controlled Trial].

    Article  PubMed  Google Scholar 

  142. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg. 2005;34(5):521–7.

    Article  CAS  PubMed  Google Scholar 

  143. Sambandham T, Masthan KM, Kumar MS, Jha A. The application of vizilite in oral cancer. J Clin Diagn Res. 2013;7(1):185–6.

    PubMed  Google Scholar 

  144. Epstein JB, Gorsky M, Lonky S, Silverman Jr S, Epstein JD, Bride M. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist. 2006;26(4):171–4. [Clinical Trial Multicenter Study Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  145. Epstein JB, Silverman Jr S, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008;44(6):538–44. [Comparative Study In Vitro Multicenter Study Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  146. Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent. 2006;17(3):59–63.

    CAS  PubMed  Google Scholar 

  147. Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions. J Craniofac Surg. 2012;23(2):e162–4.

    Article  PubMed  Google Scholar 

  148. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007;65(3):424–6. [Evaluation Studies].

    Article  PubMed  Google Scholar 

  149. Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLite) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med. 2011;40(7):541–4. [Comparative Study Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  150. Kammerer PW, Rahimi-Nedjat RK, Ziebart T, Bemsch A, Walter C, Al-Nawas B, et al. A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions-clinical evaluation and review of the literature. Clin Oral Investig. 2014;19:459–66.

    Article  PubMed  Google Scholar 

  151. Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010;141(2):151–6. [Comparative Study Randomized Controlled Trial].

    Article  PubMed  Google Scholar 

  152. Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int. 2004;35(5):378–84.

    PubMed  Google Scholar 

  153. Rajmohan M, Rao UK, Joshua E, Rajasekaran ST, Kannan R. Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology. J Oral Maxillofac Pathol. 2012;16(3):325–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Abbott KL, Aoki K, Lim J-M, Porterfield M, Johnson R, O’Regan RM, et al. Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J Proteome Res. 2008;7(4):1470–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Richards-Kortum R, Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem. 1996;47:555–606. [Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S. Review].

    Article  CAS  PubMed  Google Scholar 

  156. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res. 2008;14(8):2396–404. [Research Support, N.I.H., Extramural].

    Article  PubMed  PubMed Central  Google Scholar 

  157. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol. 1998;68(5):603–32. [Research Support, Non-U.S. Gov’t Review].

    Article  CAS  PubMed  Google Scholar 

  158. Pavlova I, Sokolov K, Drezek R, Malpica A, Follen M, Richards-Kortum R. Microanatomical and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol. 2003;77(5):550–5. [Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  159. Drezek R, Brookner C, Pavlova I, Boiko I, Malpica A, Lotan R, et al. Autofluorescence microscopy of fresh cervical-tissue sections reveals alterations in tissue biochemistry with dysplasia. Photochem Photobiol. 2001;73(6):636–41. [Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  160. Weingandt H, Stepp H, Baumgartner R, Diebold J, Xiang W, Hillemanns P. Autofluorescence spectroscopy for the diagnosis of cervical intraepithelial neoplasia. BJOG. 2002;109(8):947–51. [Evaluation Studies Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  161. Nordstrom RJ, Burke L, Niloff JM, Myrtle JF. Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy. Lasers Surg Med. 2001;29(2):118–27.

    Article  CAS  PubMed  Google Scholar 

  162. Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R. Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties. J Biomed Opt. 2009;14(1):014009. [Evaluation Studies Research Support, N.I.H., Extramural].

    Article  PubMed  Google Scholar 

  163. Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, et al. Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt. 2008;13(2):024019–11.

    Article  PubMed  Google Scholar 

  164. De Veld DC, Skurichina M, Witjes MJ, Duin RP, Sterenborg HJ, Roodenburg JL. Autofluorescence and diffuse reflectance spectroscopy for oral oncology. Lasers Surg Med. 2005;36(5):356–64.

    Article  PubMed  Google Scholar 

  165. Gillenwater A, Jacob R, Ganeshappa R, Kemp B, El-Naggar AK, Palmer JL, et al. Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. Arch Otolaryngol Head Neck Surg. 1998;124(11):1251–8.

    Article  CAS  PubMed  Google Scholar 

  166. Ingrams DR, Dhingra JK, Roy K, Perrault Jr DF, Bottrill ID, Kabani S, et al. Autofluorescence characteristics of oral mucosa. Head Neck. 1997;19(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  167. Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, et al. Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila). 2009;2(5):423–31. [Research Support, N.I.H., Extramural].

    Article  Google Scholar 

  168. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 2005;41(2):117–31. [Research Support, Non-U.S. Gov’t Review].

    Article  PubMed  Google Scholar 

  169. Majumder S, Gupta P, Uppal A. Autofluorescence spectroscopy of tissues from human oral cavity for discriminating malignant from normal. Lasers Life Sci. 1999;8(4):211–27.

    Google Scholar 

  170. Majumder S, Mohanty S, Ghosh N, Gupta P, Jain D, Khan F. A pilot study on the use of autofluorescence spectroscopy for diagnosis of the cancer of human oral cavity. Curr Sci. 2000;79(8):1089–94.

    Google Scholar 

  171. Shin D, Vigneswaran N, Gillenwater A, Richards-Kortum R. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol. 2010;6(7):1143–54. [Research Support, N.I.H., Extramural Review].

    Article  PubMed  Google Scholar 

  172. Schwarz RA, Gao W, Stepanek VM, Le TT, Bhattar VS, Williams MD, et al. Prospective evaluation of a portable depth-sensitive optical spectroscopy device to identify oral neoplasia. Biomed Opt Express. 2010;2(1):89–99.

    Article  PubMed  PubMed Central  Google Scholar 

  173. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006;11(2):024006.

    Article  PubMed  Google Scholar 

  174. Jayaprakash V, Sullivan M, Merzianu M, Rigual NR, Loree TR, Popat SR, et al. Autofluorescence-guided surveillance for oral cancer. Cancer Prev Res (Phila). 2009;2(11):966–74.

    Article  Google Scholar 

  175. Dabelsteen E, Vedtofte P, Hakomori S-i, Young WW. Accumulation of a blood group antigen precursor in oral premalignant lesions. Cancer Res. 1983;43(3):1451–4.

    CAS  PubMed  Google Scholar 

  176. Poh CF, MacAulay CE, Zhang L, Rosin MP. Tracing the “at-risk” oral mucosa field with autofluorescence: steps toward clinical impact. Cancer Prev Res (Phila Pa). 2009;2(5):401–4. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review].

    Article  Google Scholar 

  177. Wu Y, Qu JY. Autofluorescence spectroscopy of epithelial tissues. J Biomed Opt. 2006;11(5):054023. [In Vitro Research Support, Non-U.S. Gov’t].

    Article  PubMed  CAS  Google Scholar 

  178. Kois JC, Truelove E. Detecting oral cancer: a new technique and case reports. Dent Today. 2006;25(10):94. 6–7. [Case Reports].

    PubMed  Google Scholar 

  179. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 2007;29(1):71–6. [Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  180. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 2006;12(22):6716–22. [Evaluation Studies Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  181. Scheer M, Neugebauer J, Derman A, Fuss J, Drebber U, Zoeller JE. Autofluorescence imaging of potentially malignant mucosa lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(5):568–77. [Evaluation Studies Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  182. Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev: Off J Eur Cancer Prev Organ. 2012;21(5):460–6. [Randomized Controlled Trial].

    Article  Google Scholar 

  183. Marzouki HZ, Tuong Vi Vu T, Ywakim R, Chauvin P, Hanley J, Kost KM. Use of fluorescent light in detecting malignant and premalignant lesions in the oral cavity: a prospective, single-blind study. J Otolaryngol Head Neck Surg Le J d’oto-rhino-laryngologie et de chirurgie cervico-faciale. 2012;41(3):164–8.

    Google Scholar 

  184. Farah CS, McIntosh L, Georgiou A, McCullough MJ. Efficacy of tissue autofluorescence imaging (VELScope) in the visualization of oral mucosal lesions. Head Neck. 2012;34(6):856–62. [Evaluation Studies].

    Article  PubMed  Google Scholar 

  185. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011;47(4):274–7.

    Article  CAS  PubMed  Google Scholar 

  186. Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M, et al. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope) - a single blinded clinical evaluation. Head Face Med. 2013;9:23.

    Article  PubMed  PubMed Central  Google Scholar 

  187. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc. 1999;130(10):1445–57. [Clinical Trial Comparative Study Controlled Clinical Trial Multicenter Study].

    Article  CAS  PubMed  Google Scholar 

  188. Subhash N, Mallia JR, Thomas SS, Mathews A, Sebastian P, Madhavan J. Oral cancer detection using diffuse reflectance spectral ratio R540/R575 of oxygenated hemoglobin bands. J Biomed Opt. 2006;11(1):014018. [Evaluation Studies Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  189. Balevi B. Assessing the usefulness of three adjunctive diagnostic devices for oral cancer screening: a probabilistic approach. Community Dent Oral Epidemiol. 2011;39(2):171–6.

    Article  PubMed  Google Scholar 

  190. Seoane Leston J, Diz Dios P. Diagnostic clinical aids in oral cancer. Oral Oncol. 2010;46(6):418–22. [Review].

    Article  PubMed  Google Scholar 

  191. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009;1:5. [Review].

    Article  PubMed  PubMed Central  Google Scholar 

  192. Huff K, Stark PC, Solomon LW. Sensitivity of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice. Gen Dent. 2009;57(1):34–8. [Comparative Study].

    PubMed  Google Scholar 

  193. Truelove EL, Dean D, Maltby S, Griffith M, Huggins K, Griffith M, et al. Narrow band (light) imaging of oral mucosa in routine dental patients. Part I: assessment of value in detection of mucosal changes. Gen Dent. 2011;59(4):281–9; quiz 90–1, 319–20. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].

    Google Scholar 

  194. McNamara KK, Martin BD, Evans EW, Kalmar JR. The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2012;114(5):636–43.

    Article  Google Scholar 

  195. Laronde DM, Williams PM, Hislop TG, Poh C, Ng S, Bajdik C, et al. Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices. J Oral Pathol Med. 2014;43(1):7–13.

    Article  PubMed  Google Scholar 

  196. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709–28.

    Article  CAS  PubMed  Google Scholar 

  197. Do LG, Spencer AJ, Dost F, Farah CS. Oral mucosal lesions: findings from the Australian National Survey of Adult Oral Health. Aust Dent J. 2014;59(1):114–20. doi: 10.1111/adj.12143. Epub 2014 Feb 4.

  198. Bhatia N, Matias MA, Farah CS. Assessment of a decision making protocol to improve the efficacy of VELscope™ in general dental practice: a prospective evaluation. Oral Oncol. 2014;50(10):1012–9. doi: 10.1016/j.oraloncology.2014.07.002. Epub 2014 Aug 2. https://www.sciencedirect.com/science/article/abs/pii/S1368837514001948?via%3Dihub.

  199. Sharma AK, Mirza FD. Palatal mucosa under dentures: a qualitative histologic and histochemical analysis. J Prosthet Dent. 1986;56(5):574–82.

    Article  CAS  PubMed  Google Scholar 

  200. Raica M, Cimpean AM, Ribatti D. Angiogenesis in pre-malignant conditions. Eur J Cancer Prev: Off J Eur Cancer Prev Organ. 2009;45(11):1924–34.

    Article  CAS  Google Scholar 

  201. DentalIEZ Group, Identafi – Multispectral, Oral Cancer Screening Device. 2013 [cited 2013 20 March]; Available from: http://www.identafi.net/.

  202. Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, et al. The association between tumour progression and vascularity in the oral mucosa. J Pathol. 1997;183(1):39–43. [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  203. Lane P, Follen M, MacAulay C. Has fluorescence spectroscopy come of age? A case series of oral precancers and cancers using white light, fluorescent light at 405 nm, and reflected light at 545 nm using the Trimira Identafi 3000. Gend Med. 2012;9(1 Suppl):S25–35. [Research Support, N.I.H., Extramural].

    Article  PubMed  Google Scholar 

  204. Zuluaga AF, Vigneswaran N, Bradley RK, Gillenwater AM, Nichols CM, Poh C. “Identafi®3000 ultra A Multispectral Tool For Improved Oral Lesion Evaluation,” in Biomedical Optics and 3-D Imaging, OSA Technical Digest (CD) (Optical Society of America, 2010), paper BSuD105. doi:10.1364/BIOMED.2010.BSuD105.

  205. Lane P, Lam S, Follen M, MacAulay C. Oral fluorescence imaging using 405-nm excitation, aiding the discrimination of cancers and precancers by identifying changes in collagen and elastic breakdown and neovascularization in the underlying stroma. Gend Med. 2012;9(1 Suppl):S78–82.e8. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  206. Shetty DC, Ahuja P, Taneja D, Rathore AS, Chhina S, Ahuja US, et al. Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer. Vasc Health Risk Manag. 2011;7:41–7.

    Article  PubMed  PubMed Central  Google Scholar 

  207. Vu AN, Farah CS. Efficacy of narrow band imaging for detection and surveillance of potentially malignant and malignant lesions in the oral cavity and oropharynx: a systematic review. Oral Oncol. 2014;50(5):413–20. [Review]. https://www.sciencedirect.com/science/article/abs/pii/S1368837514000384?via%3Dihub#.

  208. Sweeny L, Dean NR, Magnuson JS, Carroll WR, Clemons L, Rosenthal EL. Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Curr Opin Otolaryngol Head Neck Surg. 2011;145(6):956–60. [Comparative Study Evaluation Studies Research Support, N.I.H., Extramural].

    Article  Google Scholar 

  209. Lalla Y, Matias MA, Farah CS. Assessment of oral mucosal lesions with autofluorescence imaging and reflectance spectroscopy. J Am Dent Assoc. 2016. pii: S0002–8177(16)30264–1. doi: 10.1016/j.adaj.2016.03.013. https://www.sciencedirect.com/science/article/abs/pii/S0002817716302641?via%3Dihub.

  210. Song LM, Adler DG, Conway EL, Diehl DL, Farraye FA, Kantsevoy SV, et al. Narrow band imaging and multiband imaging. Gastrointest Endosc. 2008;67(4):581–9.

    Article  PubMed  Google Scholar 

  211. Gono K, Yamazaki K, Doguchi N, Nonami T, Obi T, Yamaguchi M, et al. Endoscopic observation of tissue by narrowband illumination. Opt Rev. 2003;10(4):211–5.

    Article  Google Scholar 

  212. Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9(3):568–77. [Comparative Study Evaluation Studies Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  213. Tan NC, Herd MK, Brennan PA, Puxeddu R. The role of narrow band imaging in early detection of head and neck cancer. Br J Oral Maxillofac Surg. 2012;50(2):132–6. [Review].

    Article  PubMed  Google Scholar 

  214. Muto M, Horimatsu T, Ezoe Y, Morita S, Miyamoto S. Improving visualization techniques by narrow band imaging and magnification endoscopy. J Gastroenterol Hepatol. 2000;24:1333–46.

    Article  Google Scholar 

  215. Inoue H, Kumagai Y, Yoshida T, Kawano T, Endo M, Iwai T. High-magnification endoscopic diagnosis of the superficial esophageal caner. Digestive Endosc. 2000;12(Suppl):S32–5.

    Article  Google Scholar 

  216. Takano JH, Yakushiji T, Kamiyama I, Nomura T, Katakura A, Takano N, et al. Detecting early oral cancer: narrowband imaging system observation of the oral mucosa microvasculature. Int J Oral Maxillofac Surg. 2010;39(3):208–13.

    Article  CAS  PubMed  Google Scholar 

  217. Ni XG, He S, Xu ZG, Gao L, Lu N, Yuan Z, et al. Endoscopic diagnosis of laryngeal cancer and precancerous lesions by narrow band imaging. J Laryngol Otol. 2011;125(3):288–96. [Evaluation Studies Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  218. Li ZH, Gao W, Lei WB, Ho WK, Chan YW, Wong TS. The clinical utility of narrow band imaging in the surveillance of mucosa and submucosa lesions in head and neck regions. Head Neck Oncol. 2013;5(3):29. [Systematic literature review and meta-analysis].

    Google Scholar 

  219. Piazza C, Cocco D, Del Bon F, Mangili S, Nicolai P, Majorana A, et al. Narrow band imaging and high definition television in evaluation of oral and oropharyngeal squamous cell cancer: a prospective study. Oral Oncol. 2010;46(4):307–10. [Evaluation Studies].

    Article  CAS  PubMed  Google Scholar 

  220. Piazza C, Cocco D, Del Bon F, Mangili S, Nicolai P, Peretti G. Narrow band imaging and high definition television in the endoscopic evaluation of upper aero-digestive tract cancer. Acta Otorhinolaryngol Ital. 2011;31(2):70–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  221. Yang SW, Lee YS, Chang LC, Chien HP, Chen TA. Light sources used in evaluating oral leukoplakia: broadband white light versus narrowband imaging. Int J Oral Maxillofac Surg. 2013;42(6):693–701. [Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  222. Yang SW, Lee YS, Chang LC, Hwang CC, Chen TA. Use of endoscopy with narrow-band imaging system in detecting squamous cell carcinoma in oral chronic non-healing ulcers. Clin Oral Investig. 2014;18:949–59.

    Article  PubMed  Google Scholar 

  223. Yang SW, Lee YS, Chang LC, Hwang CC, Chen TA. Diagnostic significance of narrow-band imaging for detecting high-grade dysplasia, carcinoma in situ, and carcinoma in oral leukoplakia. Laryngoscope. 2012;122(12):2754–61. [Comparative Study].

    Article  PubMed  Google Scholar 

  224. Majorana A, Bardellini E, Bonadeo S, Flocchini P, Conti G, Piazza C. Narrow band imaging and high definitition television in evaluation of oral and oropharyngeal squamous cell carcinoma: a prospective study on 80 patients. Short submitted peer reviewed abstracts; 21–25; London: Oral Dis; 2010. p. 516–72.

    Google Scholar 

  225. Chu PY, Tsai TL, Tai SK, Chang SY. Effectiveness of narrow band imaging in patients with oral squamous cell carcinoma after treatment. Head Neck. 2012;34(2):155–61. [Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  226. Nguyen P, Bashirzadeh F, Hodge R, Agnew J, Farah CS, Duhig E, et al. High specificity of combined narrow band imaging and autofluorescence mucosal assessment of patients with head and neck cancer. Head Neck. 2012;35(5):619–25.

    Article  PubMed  Google Scholar 

  227. Tan NC, Mellor T, Brennan PA, Puxeddu R. Use of narrow band imaging guidance in the management of oral erythroplakia. Br J Oral Maxillofac Surg. 2011;49(6):488–90. [Case Reports].

    Article  PubMed  Google Scholar 

  228. Katada C, Nakayama M, Tanabe S, Naruke A, Koizumi W, Masaki T, et al. Narrow band imaging for detecting superficial oral squamous cell carcinoma: a report of two cases. Laryngoscope. 2007;117(9):1596–9. [Case Reports].

    Article  PubMed  Google Scholar 

  229. Yang SW, Lee YS, Chang LC, Chien HP, Chen TA. Clinical appraisal of endoscopy with narrow-band imaging system in the evaluation and management of homogeneous oral leukoplakia. ORL J Otorhinolaryngol Relat Spec. 2012;74(2):102–9.

    Article  PubMed  Google Scholar 

  230. Yang SW, Lee YS, Chang LC, Hwang CC, Luo CM, Chen TA. Use of endoscopy with narrow-band imaging system in evaluating oral leukoplakia. Head Neck. 2012;34(7):1015–22.

    Article  PubMed  Google Scholar 

  231. Yang SW, Lee YS, Chang LC, Hsieh TY, Chen TA. Implications of morphologic patterns of intraepithelial microvasculature observed by narrow-band imaging system in cases of oral squamous cell carcinoma. Oral Oncol. 2013;49(1):86–92.

    Article  PubMed  Google Scholar 

  232. Yoshimura N, Goda K, Tajiri H, Yoshida Y, Kato T, Seino Y, et al. Diagnostic utility of narrow-band imaging endoscopy for pharyngeal superficial carcinoma. World J Gastroenterol. 2011;17(45):4999–5006. [Research Support, Non-U.S. Gov’t].

    Article  PubMed  PubMed Central  Google Scholar 

  233. Lin YC, Wang WH, Lee KF, Tsai WC, Weng HH. Value of narrow band imaging endoscopy in early mucosal head and neck cancer. Head Neck. 2012;34(11):1574–9.

    Article  PubMed  Google Scholar 

  234. Vu AN, Matias MA, Farah CS. Diagnostic accuracy of Narrow Band Imaging for the detection of oral potentially malignant disorders. Oral Dis. 2015;21:519–29. https://onlinelibrary.wiley.com/doi/abs/10.1111/odi.12315.

  235. Wang TD, Van Dam J. Optical biopsy: a new frontier in endoscopic detection and diagnosis. Clin Gastroenterol Hepatol. 2004;2(9):744–53.

    Article  PubMed  Google Scholar 

  236. Keereweer S, Kerrebijn JD, van Driel PB, Xie B, Kaijzel EL, Snoeks TJ, et al. Optical image-guided surgery--where do we stand? Mol Imaging Biol. 2011;13(2):199–207.

    Article  PubMed  Google Scholar 

  237. Zhu Y, Terry NG, Wax A. Angle-resolved low-coherence interferometry: an optical biopsy technique for clinical detection of dysplasia in Barretts esophagus. Expert Rev Gastroenterol Hepatol. 2012;6(1):37–41.

    Article  PubMed  PubMed Central  Google Scholar 

  238. Hamdoon Z, Jerjes W, Upile T, McKenzie G, Jay A, Hopper C. Optical coherence tomography in the assessment of suspicious oral lesions: an immediate ex vivo study. Photodiagnosis Photodyn Ther. 2013;10(1):17–27.

    Article  PubMed  Google Scholar 

  239. Adhi M, Duker JS. Optical coherence tomography-current and future applications. Curr Opin Ophthalmol. 2013;24(3):213–21.

    Article  PubMed  Google Scholar 

  240. Whiteman SC, Yang Y, Gey van Pittiu D, Stephens M, Parmer J, Spiteri MA. Optical coherence tomography: real-time imaging of bronchial airways microstructure and detection of inflammatory/neoplastic morphologic changes. Clin Cancer Res. 2006;12(3 Pt 1):813–8.

    Article  PubMed  CAS  Google Scholar 

  241. Lee CK, Tsai MT, Lee HC, Chen HM, Chiang CP, Wang YM, et al. Diagnosis of oral submucous fibrosis with optical coherence tomography. J Biomed Opt. 2009;14(5):054008.

    Article  PubMed  Google Scholar 

  242. Ozawa N, Sumi Y, Shimozato K, Chong C, Kurabayashi T. In vivo imaging of human labial glands using advanced optical coherence tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(3):425–9.

    Article  PubMed  Google Scholar 

  243. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol. 2003;21(11):1361–7.

    Article  CAS  PubMed  Google Scholar 

  244. Brezinski ME, Tearney GJ, Boppart SA, Swanson EA, Southern JF, Fujimoto JG. Optical biopsy with optical coherence tomography: feasibility for surgical diagnostics. J Surg Res. 1997;71(1):32–40.

    Article  CAS  PubMed  Google Scholar 

  245. Hughes OR, Stone N, Kraft M, Arens C, Birchall MA. Optical and molecular techniques to identify tumor margins within the larynx. Head Neck. 2010;32(11):1544–53.

    Article  PubMed  Google Scholar 

  246. Hamdoon Z, Jerjes W, Al-Delayme R, McKenzie G, Jay A, Hopper C. Structural validation of oral mucosal tissue using optical coherence tomography. Head Neck Oncol. 2012;4(1):29.

    Article  PubMed  PubMed Central  Google Scholar 

  247. Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, et al. In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg. 2010;48(1):18–25.

    Article  PubMed  Google Scholar 

  248. Savastru D, Chang EW, Miclos S, Pitman MB, Patel A, Iftimia N. Detection of breast surgical margins with optical coherence tomography imaging: a concept evaluation study. J Biomed Opt. 2014;19(5):056001.

    Article  PubMed  Google Scholar 

  249. South FA, Chaney EJ, Marjanovic M, Adie SG, Boppart SA. Differentiation of ex vivo human breast tissue using polarization-sensitive optical coherence tomography. Biomed Opt Express. 2014;5(10):3417–26.

    Article  PubMed  PubMed Central  Google Scholar 

  250. Alawi SA, Kuck M, Wahrlich C, Batz S, McKenzie G, Fluhr JW, et al. Optical coherence tomography for presurgical margin assessment of non-melanoma skin cancer - a practical approach. Exp Dermatol. 2013;22(8):547–51.

    Article  PubMed  Google Scholar 

  251. Pelosini L, Smith HB, Schofield JB, Meeckings A, Dhital A, Khandwala M. In vivo optical coherence tomography (OCT) in periocular basal cell carcinoma: correlations between in vivo OCT images and postoperative histology. Br J Ophthalmol. 2013;97(7):890–4.

    Article  PubMed  Google Scholar 

  252. Wessels R, van Beurden M, de Bruin DM, Faber DJ, Vincent AD, Sanders J, et al. The value of optical coherence tomography in determining surgical margins in squamous cell carcinoma of the vulva: a single-center prospective study. Int J Gynecol Cancer. 2014;31.

    Google Scholar 

  253. Skarecky DW, Brenner M, Rajan S, Rodriguez Jr E, Narula N, Melgoza F, et al. Zero positive surgical margins after radical prostatectomy: is the end in sight. Expert Rev Med Devices. 2008;5(6):709–17.

    Article  PubMed  Google Scholar 

  254. Pyhtila JW, Chalut KJ, Boyer JD, Keener J, D’Amico T, Gottfried M, et al. In situ detection of nuclear atypia in barrett’s esophagus by using angle-resolved low-coherence interferometry. Gastrointest Endosc. 2007;65(3):487–91.

    Article  PubMed  Google Scholar 

  255. Terry NG, Zhu Y, Rinehart MT, Brown WJ, Gebhart SC, Bright S, et al. Detection of dysplasia in barrett’s esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology. 2011;140(1):42–50.

    Article  PubMed  Google Scholar 

  256. Kelloff GJ, Sigman CC. Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development. Nat Rev Cancer. 2007;7(7):508–18.

    Article  CAS  PubMed  Google Scholar 

  257. Backman V, Wallace MB, Perelman LT, Arendt JT, Gurjar R, Muller MG, et al. Detection of preinvasive cancer cells. Nature. 2000;406(6791):35–6.

    Article  CAS  PubMed  Google Scholar 

  258. Bakker Schut TC, Witjes MJ, Sterenborg HJ, Speelman OC, Roodenburg JL, Marple ET, et al. In vivo detection of dysplastic tissue by Raman spectroscopy. Anal Chem. 2000;72(24):6010–8.

    Article  CAS  PubMed  Google Scholar 

  259. Kendall C, Stone N, Shepherd N, Geboes K, Warren B, Bennett R, et al. Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett’s oesophagus. J Pathol. 2003;200(5):602–9.

    Article  PubMed  Google Scholar 

  260. Shim MG, Song LM, Marcon NE, Wilson BC. In vivo near-infrared Raman spectroscopy: demonstration of feasibility during clinical gastrointestinal endoscopy. Photochem Photobiol. 2000;72(1):146–50.

    CAS  PubMed  Google Scholar 

  261. Molckovsky A, Song LM, Shim MG, Marcon NE, Wilson BC. Diagnostic potential of near-infrared Raman spectroscopy in the colon: differentiating adenomatous from hyperplastic polyps. Gastrointest Endosc. 2003;57(3):396–402.

    Article  PubMed  Google Scholar 

  262. Haka AS, Volynskaya Z, Gardecki JA, Nazemi J, Lyons J, Hicks D, et al. In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. Cancer Res. 2006;66(6):3317–22.

    Article  CAS  PubMed  Google Scholar 

  263. Stone N, Stavroulaki P, Kendall C, Birchall M, Barr H. Raman spectroscopy for early detection of laryngeal malignancy: preliminary results. Laryngoscope. 2000;110(10 Pt 1):1756–63.

    Article  CAS  PubMed  Google Scholar 

  264. Lau DP, Huang Z, Lui H, Anderson DW, Berean K, Morrison MD, et al. Raman spectroscopy for optical diagnosis in the larynx: preliminary findings. Lasers Surg Med. 2005;37(3):192–200.

    Article  PubMed  Google Scholar 

  265. Keller MD, Wilson RH, Mycek MA, Mahadevan-Jansen A. Monte Carlo model of spatially offset Raman spectroscopy for breast tumor margin analysis. Appl Spectrosc. 2010;64(6):607–14.

    Article  CAS  PubMed  Google Scholar 

  266. Ellis DI, Cowcher DP, Ashton L, O’Hagan S, Goodacre R. Illuminating disease and enlightening biomedicine: Raman spectroscopy as a diagnostic tool. Analyst. 2013;138(14):3871–84.

    Article  CAS  PubMed  Google Scholar 

  267. Olivo M, Bhuvaneswari R, Keogh I. Advances in bio-optical imaging for the diagnosis of early oral cancer. Pharmaceutics. 2011;3(3):354–78.

    Article  PubMed  Google Scholar 

  268. Tollefson M, Magera J, Sebo T, Cohen J, Drauch A, Maier J, et al. Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology? BJU Int. 2010;106(4):484–8.

    Article  PubMed  Google Scholar 

  269. Crow P, Uff JS, Farmer JA, Wright MP, Stone N. The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro. BJU Int. 2004;93(9):1232–6.

    Article  CAS  PubMed  Google Scholar 

  270. Chi C, Du Y, Ye J, Kou D, Qiu J, Wang J, et al. Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology. Theranostics. 2014;4(11):1072–84.

    Article  PubMed  Google Scholar 

  271. Dammann F, Bootz F, Cohnen M, Hassfeld S, Tatagiba M, Kosling S. Diagnostic imaging modalities in head and neck disease. Dtsch Arztebl Int. 2014;111(23–24):417–23.

    PubMed  Google Scholar 

  272. Hussain T, Nguyen QT. Molecular imaging for cancer diagnosis and surgery. Adv Drug Deliv Rev. 2014;66:90–100.

    Article  CAS  PubMed  Google Scholar 

  273. Shah AT, Demory Beckler M, Walsh AJ, Jones WP, Pohlmann PR, Skala MC. Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma. PLoS One. 2014;9(3):e90746.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  274. Nguyen QT, Tsien RY. Fluorescence-guided surgery with live molecular navigation--a new cutting edge. Nat Rev Cancer. 2013;13(9):653–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  275. Kircher MF, Willmann JK. Molecular body imaging: MR imaging, CT, and US. Part I principles. Radiol. 2012;263(3):633–43.

    Article  Google Scholar 

  276. Elias DR, Thorek DLJ, Chen AK, Czupryna J, Tsourkas A. In vivo imaging of cancer biomarkers using activatable molecular probes. Cancer Biomark. 2008;4(6):287–305.

    Article  CAS  PubMed  Google Scholar 

  277. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10(8):789–99.

    Article  CAS  PubMed  Google Scholar 

  278. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452(7187):580–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  279. Heuveling DA, de Bree R, van Dongen GA. The potential role of non-FDG-PET in the management of head and neck cancer. Oral Oncol. 2011;47(1):2–7.

    Article  CAS  PubMed  Google Scholar 

  280. Hoeben BA, Starmans MH, Leijenaar RT, Dubois LJ, van der Kogel AJ, Kaanders JH, et al. Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors. BMC Cancer. 2014;14:130.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  281. Loja MN, Luo Z, Greg Farwell D, Luu QC, Donald PJ, Amott D, et al. Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer. Int J Cancer J Int du Cancer. 2013;132(7):1613–23.

    Article  CAS  Google Scholar 

  282. Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, et al. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope. 2000;110(1):78–83. [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  283. Chang C-J, Wilder-Smith P. Topical application of photofrin for photodynamic diagnosis of oral neoplasms. Plast Reconstr Surg. 2005;115(7):1877–86.

    Article  CAS  PubMed  Google Scholar 

  284. Sharwani A, Jerjes W, Salih V, MacRobert A, El-Maaytah M, Khalil H, et al. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B. 2006;83(1):27–33.

    Article  CAS  PubMed  Google Scholar 

  285. Fortes DL, Allen MS, Lowe VJ, Shen K-HR, Wigle DA, Cassivi SD, et al. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules. Eur J Cardiothorac Surg. 2008;34(6):1223–7.

    Article  PubMed  Google Scholar 

  286. Nitin N, Carlson AL, Muldoon T, El-Naggar AK, Gillenwater A, Richards-Kortum R. Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose. Int J Cancer. 2009;124(11):2634–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  287. Ang KK, Berkey BA, Tu X, Zhang H-Z, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002;62(24):7350–6.

    CAS  PubMed  Google Scholar 

  288. Nitin N, Rosbach KJ, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum RR. Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. Neoplasia. 2009;11(6):542–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  289. Vigneswaran N, Peters KP, Hornstein OP, Diepgen TL. Alteration of cell surface carbohydrates associated with ordered and disordered proliferation of oral epithelia: a lectin histochemical study in oral leukoplakias, papillomas and carcinomas. Cell Tissue Kinet. 1990;23(1):41–55.

    CAS  PubMed  Google Scholar 

  290. Sanjay P, Hallikeri K, Shivashankara A. Evaluation of salivary sialic acid, total protein, and total sugar in oral cancer: a preliminary report. Indian J Dent Res. 2008;19(4):288.

    Article  CAS  PubMed  Google Scholar 

  291. Raval G, Patel D, Parekh L, Patel J, Shah M, Patel P. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer. Oral Dis. 2003;9(3):119–28.

    Article  CAS  PubMed  Google Scholar 

  292. Rajpura KB, Patel PS, Chawda JG, Shah RM. Clinical significance of total and lipid bound sialic acid levels in oral pre‐cancerous conditions and oral cancer. J Oral Pathol Med. 2005;34(5):263–7.

    Article  CAS  PubMed  Google Scholar 

  293. Silvia CW, Vasudevan D, Prabhu KS. Evaluation of serum glycoproteins in oral carcinoma. Indian J Clin Biochem. 2001;16(1):113–5.

    Article  Google Scholar 

  294. Joshi M, Patil R. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer. J Cancer Res Ther. 2010;6(3):263.

    Article  PubMed  Google Scholar 

  295. Baeten J, Suresh A, Johnson A, Patel K, Kuriakose M, Flynn A, et al. Molecular Imaging of Oral Premalignant and Malignant Lesions Using Fluorescently Labeled Lectins. Transl Oncol. 2014;7(2):213–20.

    Article  PubMed  PubMed Central  Google Scholar 

  296. Farah C, John K, Wu J. Contemporary assessment and management of head and neck cancer. 2015.

    Google Scholar 

  297. Ford PJ, Farah S. Early detection and diagnosis of oral cancer: Strategies for improvement. 2013. https://www.sciencedirect.com/science/article/pii/S2213538313000039?via%3Dihub.

Download references

Acknowledgements

CSF wishes to acknowledge the contributions of members, past and present, of the Oral Oncology Research Program, UQ Centre for Clinical Research for their contribution to research undertaken into oral cancer early detection and diagnostic adjuncts.

Conflict of Interest Statement

The author declares that he has no personal or financial conflict of interest to declare in relation to the work presented in this chapter. CSF undertakes clinical and laboratory research into oral cancer and pre-cancer early detection, imaging, surgical margin delineation and molecular genomics utilising various technologies listed in this chapter, but has no financial relationship with any of the manufacturers which may bias this work.

Author information

Authors and Affiliations

  1. The Australian Centre for Oral Oncology Research & Education (ACORE), School of Dentistry, University of Western Australia, 17 Monash Ave, Nedlands, WA, 6009, Australia

    Camile S. Farah MDSc, PhD, FRACDS (OralMed)

  2. The Australian Centre for Oral Oncology Research & Education (ACORE), School of Dentistry, University of Western Australia, Nedlands, WA, 6009, Australia

    Nirav Bhatia BDSc, MPhil, Yastira Lalla BDSc, MPhil, An Vu BDSc, MPhil & Keziah John BDSc, MPhil

  3. Roswell Park Cancer Institute, Buffalo, NY, USA

    Vishal Gupta MD

  4. Vista Dental, 2200 South St. Ste. A, Racine, WI, 53404, USA

    John Baeten MSc & Alexander Johnson MSc

  5. Department of Surgery, Oral and Maxillofacial Surgery, Oral/Head and Neck Oncologic and Reconstructive Surgery, North Memorial and Hubert Humphrey Cancer Center, Minneapolis, MN, USA

    Deepak Kademani DMD, MD, FACS

Authors
  1. Camile S. Farah MDSc, PhD, FRACDS (OralMed)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nirav Bhatia BDSc, MPhil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yastira Lalla BDSc, MPhil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. An Vu BDSc, MPhil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keziah John BDSc, MPhil
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vishal Gupta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John Baeten MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alexander Johnson MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Deepak Kademani DMD, MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camile S. Farah MDSc, PhD, FRACDS (OralMed) .

Editor information

Editors and Affiliations

  1. Department of Head and Neck, Plastic and Reconstructive Surgery, Roswell Park Cancer Institute, Buffalo, USA

    Moni Abraham Kuriakose

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Farah, C.S. et al. (2017). Advances in Early Detection and Diagnostic Adjuncts in Oral Cavity Cancer. In: Kuriakose, M.A. (eds) Contemporary Oral Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-14911-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14911-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14910-3

  • Online ISBN: 978-3-319-14911-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation